NeueHealth, Inc. (NYSE:NEUE – Get Free Report) insider Jeffery Michael Craig sold 2,486 shares of the business’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $7.33, for a total value of $18,222.38. Following the completion of the transaction, the insider now directly owns 7,558 shares of the company’s stock, valued at approximately $55,400.14. This trade represents a 24.75 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
NeueHealth Stock Performance
NYSE NEUE traded up $0.05 during mid-day trading on Wednesday, reaching $7.45. 38,124 shares of the stock were exchanged, compared to its average volume of 70,685. The company has a market capitalization of $61.72 million, a P/E ratio of -0.15 and a beta of 0.57. The business’s 50 day moving average is $5.47 and its 200-day moving average is $5.38. NeueHealth, Inc. has a 1 year low of $3.79 and a 1 year high of $16.59.
Institutional Investors Weigh In On NeueHealth
Hedge funds have recently modified their holdings of the company. Renaissance Technologies LLC purchased a new position in shares of NeueHealth during the 2nd quarter valued at approximately $312,000. Partners Group Holding AG acquired a new position in NeueHealth during the third quarter worth $463,000. Deer Management Co. LLC purchased a new position in NeueHealth during the second quarter valued at $5,436,000. Finally, NEA Management Company LLC acquired a new stake in shares of NeueHealth in the second quarter valued at about $14,834,000. 63.88% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Read Our Latest Stock Analysis on NeueHealth
About NeueHealth
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Read More
- Five stocks we like better than NeueHealth
- What Do S&P 500 Stocks Tell Investors About the Market?
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- What Are Growth Stocks and Investing in Them
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Where Do I Find 52-Week Highs and Lows?
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.